Benzinga's M&A Chatter for Tuesday September 11, 2012

The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday September 11, 2012: Mellanox Reports B‌eing Approached Multiple Times by Potential Buyers The Offers:
Mellanox Technologies MLNX reported Tuesday that the company has been approached multiple times by potential buyers, according to CEO Eyal Waldman speaking to Reuters. Oracle ORCL currently has a 10% stake in Mellanox, Fidelity owns 14%. Mellanox Technologies closed at $102.41 Tuesday, a gain of 0.75% on 2.5 time saverage volume. Monster Worldwide Says Still in Sale Process The Rumor:
A Monster Worldwide MWW spokesperson told Benzinga Tuesday the company is still in talks to sell itself. There was chatter last week that the company was in the final stages of a bidding process that might include Microsoft MSFT, Oracle ORCL, News Corp NWSA and Salesforce.com CRM. There was a sharp selloff in Monster shares at around 10:45am. The Monster spokesperson had no news to account for the move. Monster Worldwide closed at $7.91 Tuesday, a loss of 2.94% on 2.5 times average volume. Blog Post Says Pfizer Could Buy Amarin The Rumor:
Pfizer PFE could buy Amarin AMRN, according to the blog Buyvascepa.com. Spokespersons for Amarin and Pfizer were not available for comment. Amarin closed at $13.56 Tuesday, a loss of 5.90% on 1.5 times average volume.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsRumorsM&AAfter-Hours CenterMovers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!